Mercaptopurine 50 mg tablets are primarily used in treating certain types of cancer and inflammatory bowel disease.
Cancer Treatment:
- Acute lymphoblastic leukemia (ALL): Mercaptopurine is a key component of chemotherapy regimens for ALL, often used in combination with other medications. Acute myelogenous leukemia (AML): It may be used in some AML treatment protocols, typically in combination therapy. Other leukemias and lymphomas: Use varies depending on the specific type and stage of the disease and is determined by your oncologist.
Inflammatory Bowel Disease (IBD):
- Crohn’s disease: Mercaptopurine can help manage Crohn’s disease symptoms, reducing inflammation and improving patient well-being. Dosage and duration are determined by your gastroenterologist. Ulcerative colitis: Though less common than in Crohn’s, it may be used in cases unresponsive to other treatments. Your doctor will assess its suitability.
Important Note: This information is for general knowledge only and does not substitute professional medical advice. Always consult your doctor or pharmacist before starting or changing any medication. They will assess your specific medical history, condition, and other medications to determine the appropriate dosage and monitor for side effects.
Dosage is individualized. Regular monitoring of blood counts is necessary. Report any unusual side effects immediately.
